Search results
Erik Canuel, ‘Bon Cop, Bad Cop’ Director, Dies at 63
The Hollywood Reporter· 5 days agoVeteran Quebec director Erik Canuel, best known for his box office hit Bon Cop, Bad Cop, has died. Canuel died on June 15 in Montreal after complications...
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel...
Morningstar· 4 days agoALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure RatesFirst Prospective Trial to Incorporate the Foresight Diagnostics’s Investigational CLARITY™ Test to Identify Patients with LBCL Who
Genmab A/S’s (GMAB) “Buy” Rating Reiterated at HC Wainwright
ETF DAILY NEWS· 4 days agoGenmab A/S (NASDAQ:GMAB – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports. HC Wainwright’s price ...
General Hospital’s John J. York Opens Up About His Emotional Return — But Where In the World Has Mac...
SheKnows· 4 days agoGeneral Hospital's John J. York opens up about his return to Port Charles after his cancer battle,...
Roswell Park Insights on Role of Exportin 1 Protei | Newswise
Newswise· 5 days agoResearch by Hemn Mohammadpour, DVM, PhD, and colleagues at Roswell Park Comprehensive Cancer Center offers new insights into tumor biology and may lay the
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Digital Journal· 5 days agoTORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Coeptis Therapeutics (NASDAQ:COEP) Downgraded to Hold at LADENBURG THALM/SH SH
ETF DAILY NEWS· 2 days agoLADENBURG THALM/SH SH cut shares of Coeptis Therapeutics (NASDAQ:COEP – Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com ...
FDA Expands Orphan Drug Designation for SurVaxM, I | Newswise
Newswise· 4 days agoBUFFALO, N.Y. — The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer ...
Gateway - The Root
The Root· 6 days agoIn an exclusive interview with NBC News, Mutulu Shakur detailed life post-incarceration. Shakur, who is Tupac Shakur’s stepfather, was released on parole from federal prison on Dec. 16 after ...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 2 days agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....